 Partnership Will Provide Pharmaceutical Grade Cannabinoid Active Ingredients to the Largest Pharmaceutical and Consumer Goods Names in the Industry BUFFALO, N.Y., Jan. 23, 2023 GLOBE NEWSWIRE 22nd Century Group, Inc. Nasdaq: XXII, a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hempcannabis and hops advanced plant technologies, today announced filing of ... The post 22nd Century Group XXII Announces Filing of U.S. DMF Drug Master File for C... 